Whoa! We average 60,000+ unique weekly readers!

FeaturedNews

Ulster University In Eye Research Partnership With US Genetic Science Leader

1 Mins read

Ulster University and Avellino Labs, a global leader in genetic science for eye health, have formed a research partnership that could revolutionise personalised treatments for eye diseases around the world.

The collaboration will focus on developing state-of-the-art gene therapy treatments for hereditary eye conditions, primarily corneal dystrophies which are a leading cause of blindness worldwide. The research will also investigate the potential for the wider use of the treatments for other eye or ophthalmologic conditions.

California-based Avellino Labs develops new applications for genetic analysis of various eye conditions. The company uses gene editing technology to create new treatments for inherited eye diseases.

As part of the collaboration, Professor Tara Moore, Director of Ulster University’s Biomedical Sciences Research Institute, and a world-renowned specialist in ophthalmologic research, will also take up a position of Director of R&D with Avellino Labs.

Professor Moore said: “Ulster University has an international reputation in personalised medicine research, which enables treatments for a wide variety of diseases to be tailored to individual patients, enhancing the management of chronic conditions and the overall effectiveness of treatment. Our work in this area makes Ulster University the perfect fit for a global leader like Avellino.

“The partnership will enable Avellino to access world-leading gene therapy advances pioneered by a team of Ulster University scientists and accelerate its move from the laboratory to clinical use in humans. Specifically we will focus on a type of genome editing called CRISPR. This technology allows only the affected, mutated part of the genetic make up – or DNA – in a cell to be altered, essentially removing or fixing the cause of the hereditary eye condition without affecting the rest of the cell.

“This is some of the most advanced technology currently available in the personalised medicine space, making Ulster University’s partnership with Avellino a strategic move which will enable both organisations to further research objectives and ultimately deliver new treatments and therapies for genetic eye diseases worldwide.”

Gene Lee, Chairman and Founder of Avellino Labs, stated: “We were the first movers in DNA testing for genetic diseases of the cornea. We are now looking to be the global leader in gene therapy for corneal diseases by partnering genetic diagnostics and therapeutics for personalised patient eye care.”

10827 posts

About author
An article that is attributed to the Causeway Coast Community Team has either involved multiple authors, written by a contributor or the main body of content is from a press release. Got a news-related tip you’d like to see covered on Causeway Coast Community? Email us - [email protected]
Articles
Related posts
News

Bid for Belfast to host Armed Forces Day 2022 slammed by Sinn Fein

1 Mins read
FacebookTwitterPinterestWhatsAppA bid to bring Armed Forces Day to Belfast has been condemned by Sinn Fein. The last Armed Forces Day in Northern…
Featured

Executive statement on Coronavirus Health Regulations

1 Mins read
FacebookTwitterPinterestWhatsAppThe Executive has today agreed changes to the Coronavirus Health Regulations to reduce the numbers who can gather indoors and outdoors, including…
News

Murphy allocates funds for health, childcare and free school meals

1 Mins read
FacebookTwitterPinterestWhatsAppFinance Minister Conor Murphy today allocated over £250 million as part of the 2020-21 June monitoring round process. Announcing the funding, Minister…

Leave a Reply

Your email address will not be published. Required fields are marked *